Lectures related to Understanding Tau Pathologies

Protein Aggregation in Neurodegenerative Diseases

Explores protein aggregation in neurodegenerative diseases, emphasizing the need to rethink treatment strategies and understand the role of post-translational modifications.

Protein self-assembly and phase transitions

Delves into protein self-assembly, phase transitions, and aggregation mechanisms in diseases like Alzheimer's.

Parkinson's Disease Alpha-Synuclein: Amyloid Formation and Cross-reactivity

Explores Parkinson's alpha-synuclein cross-reactivity, amyloid formation, compound impact, and copper chaperones.

Parkinson's Disease: Genetic Factors

Explores genetic factors in Parkinson's disease, focusing on a-synuclein, Parkin, and PINK1, and their impact on mitochondrial quality control.

Cryo-EM and Parkinson's Disease

Delves into Cryo-EM's role in studying Parkinson's Disease and protein structures at the nano-level.

Parkinson's Disease: Pathology and Progression

Explores Parkinson's disease pathology, progression, spreading mechanisms, and initiation sites.

DNAJB6: Chaperone Action & Nuclear Pore Assembly

Delves into DNAJB6's chaperone action, relevance to protein aggregation diseases, and interactions with various proteins.

Multifactorial Diseases MOOC: Neuroscience Reconstructed: Genetics and Brain Development

Explores genetic mutations in multifactorial diseases like Alzheimer's and Parkinson's.

Neurological Disorders: Alzheimer's & Anxiety

Explores Alzheimer's disease, anxiety, pain, and the renin-angiotensin system, including the development of the first renin inhibitor for clinical treatment.

Explores SERF-related proteins' functions in amyloid acceleration and G-quadruplex binding, shedding light on their complex mechanisms.

Protein Aggregation Mechanisms: C. elegans Model Insights

Delves into protein aggregation mechanisms using C. elegans, covering misfolding, aggregation pathways, kinetics, chaperones, and stochastic nucleation.

Polyglutamine Protein Aggregation: Molecular Structure and Pathogenic Mechanisms

Explores beta-hairpins in polyglutamine protein aggregation, focusing on Huntington's disease and the molecular mechanisms behind toxic fibril formation.

Chaperone-Mediated Disaggregation: Amyloid Fibrils and Hsp70

Explores chaperone-mediated disaggregation of amyloid fibrils by Hsp70 in neurodegenerative diseases.

The Molecular Interactions that Shape Tau Polymorphs

Explores the molecular interactions shaping tau polymorphs and the role of Hsp40s in regulating tau aggregation.

Protein Aggregation and Disaggregation: Insights from In Vivo Studies

Explores protein aggregation and disaggregation mechanisms, focusing on huntingtin protein in Huntington's Disease.

Amyloid-beta Pathology in C. elegans: Neuronal Seeds of Pathogenicity

Introduces a novel C. elegans model for studying Amyloid-beta pathology in Alzheimer's Disease, focusing on specific neuronal seeds of pathogenicity.

Parkinson's Disease: Basal Ganglia Circuitry

Explores the basal ganglia circuitry in Parkinson's disease, covering structure, function, dopamine role, pathology, and treatments.

Deleterious Phase Transitions in ALS/FTD

Explores the connection between ALS and FTD, focusing on genetic overlap, protein inclusions, and therapeutic strategies.

Proteinopathy Mapping: Connecting Proteotoxicity to Intrinsic Functions

Explores proteinopathy mapping, connecting proteotoxicity to intrinsic functions of aggregation-prone proteins, with a focus on alpha-synuclein and Parkinson's Disease.

Polymer Structure and Biological Relevance

Covers the molecular structure of polymers, the transcription process, and the implications of protein misfolding in diseases.